Advertisement
Research Article| Volume 294, P6-13, May 15, 2016

Download started.

Ok

Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice

  • Author Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Ming Zhao
    Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China

    Department of Neurology, Chinese PLA 254 Hospital, Tianjin, China
    Search for articles by this author
  • Author Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Ming-Dong Liu
    Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Author Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Ying-Yan Pu
    Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Dan Wang
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Yu Xie
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Gai-Ci Xue
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Yong Jiang
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Qian-Qian Yang
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Xue-Jun Sun
    Correspondence
    Corresponding authors.
    Affiliations
    Department of Aviation Medicine, Faculty of Naval Medicine, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Li Cao
    Correspondence
    Corresponding authors.
    Affiliations
    Institute of Neuroscience and Key Laboratory of Molecular Neurobiology of the Ministry of Education, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China
    Search for articles by this author
  • Author Footnotes
    1 Ming Zhao, Ming-Dong Liu and Ying-Yan Pu contributed equally to this work.

      Highlights

      • HRW reduced the clinical score of EAE.
      • HRW altered EAE by inhibiting inflammatory infiltration and demyelination of CNS.
      • HRW functions in EAE development largely by affecting the CD4+ population.
      • HRW inhibiting Th17 cell differentiation in CNS and peripheral immune organs

      Abstract

      Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS). The high costs, inconvenient administration, and side effects of current Food and Drug Administration (FDA)-approved drugs often lead to poor adherence to the long-term treatment of MS. Molecular hydrogen (H2) has been reported to exhibit anti-oxidant, anti-apoptotic, anti-inflammatory, anti-allergy, and anti-cancer effects. In the present study, we explored the prophylactic and therapeutic effects of hydrogen-rich water (HRW) on the progress of experimental autoimmune encephalomyelitis (EAE), the animal model for MS. We found that prophylactic administration of both 0.36 mM and 0.89 mM HRW was able to delay EAE onset and reduce maximum clinical scores. Moreover, 0.89 mM HRW also reduced disease severity, CNS infiltration, and demyelination when administered after the onset of disease. Furthermore, HRW treatment prevented infiltration of CD4+ T lymphocytes into the CNS and inhibited Th17 cell development without affecting Th1 cell populations. Because HRW is non-toxic, inexpensive, easily administered, and can readily cross the blood–brain barrier, our experiments suggest that HRW may have great potential in the treatment of MS.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bauer J.
        • Berkenbosch F.
        • Van Dam A.M.
        • Dijkstra C.D.
        Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level.
        J. Neuroimmunol. 1993; 48: 13-21
        • Bettelli E.
        • Das M.P.
        • Howard E.D.
        • Weiner H.L.
        • Sobel R.A.
        • Kuchroo V.K.
        IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
        J. Immunol. 1998; 161: 3299-3306
        • Castro-Borrero W.
        • Graves D.
        • Frohman T.C.
        • Flores A.B.
        • Hardeman P.
        • Logan D.
        • Orchard M.
        • Greenberg B.
        • Frohman E.M.
        Current and emerging therapies in multiple sclerosis: a systematic review.
        Ther. Adv. Neurol. Disord. 2012; 5: 205-220
        • Croxford J.L.
        • Feldmann M.
        • Chernajovsky Y.
        • Baker D.
        Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system.
        J. Immunol. 2001; 166: 4124-4130
        • Cua D.J.
        • Groux H.
        • Hinton D.R.
        • Stohlman S.A.
        • Coffman R.L.
        Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis.
        J. Exp. Med. 1999; 189: 1005-1010
        • Das H.
        • Reddy G.R.
        • More T.
        • Singh V.K.
        In vitro effects of certain membrane-acting agents on superoxide and hydrogen peroxide production, protein synthesis and membrane ATPase activity in buffalo PMN cells.
        Altern. Lab. Anim. 2007; 35: 397-404
        • Du C.
        • Liu C.
        • Kang J.
        • Zhao G.
        • Ye Z.
        • Huang S.
        • Li Z.
        • Wu Z.
        • Pei G.
        MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis.
        Nat. Immunol. 2009; 10: 1252-1259
        • Dubois B.
        • Masure S.
        • Hurtenbach U.
        • Paemen L.
        • Heremans H.
        • van den Oord J.
        • Sciot R.
        • Meinhardt T.
        • Hammerling G.
        • Opdenakker G.
        • Arnold B.
        Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.
        J. Clin. Invest. 1999; 104: 1507-1515
        • Ekuni D.
        • Tomofuji T.
        • Endo Y.
        • Kasuyama K.
        • Irie K.
        • Azuma T.
        • Tamaki N.
        • Mizutani S.
        • Kojima A.
        • Morita M.
        Hydrogen-rich water prevents lipid deposition in the descending aorta in a rat periodontitis model.
        Arch. Oral Biol. 2012; 57: 1615-1622
        • Frohman E.M.
        • Racke M.K.
        • Raine C.S.
        Multiple sclerosis—the plaque and its pathogenesis.
        N. Engl. J. Med. 2006; 354: 942-955
        • Gilgun-Sherki Y.
        • Melamed E.
        • Offen D.
        The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
        J. Neurol. 2004; 251: 261-268
        • Goldmann T.
        • Prinz M.
        Role of microglia in CNS autoimmunity.
        Clin. Dev. Immunol. 2013; 2013: 208093
        • Han L.
        • Tian R.
        • Yan H.
        • Pei L.
        • Hou Z.
        • Hao S.
        • Li Y.V.
        • Tian Q.
        • Liu B.
        • Zhang Q.
        Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins.
        Brain Res. 2015; 1615: 129-138
        • Hu W.
        • Troutman T.D.
        • Edukulla R.
        • Pasare C.
        Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment.
        Immunity. 2011; 35: 1010-1022
        • Ishibashi T.
        • Sato B.
        • Rikitake M.
        • Seo T.
        • Kurokawa R.
        • Hara Y.
        • Naritomi Y.
        • Hara H.
        • Nagao T.
        Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study.
        Med. Gas Res. 2012; 2: 27
        • Itoh T.
        • Hamada N.
        • Terazawa R.
        • Ito M.
        • Ohno K.
        • Ichihara M.
        • Nozawa Y.
        • Ito M.
        Molecular hydrogen inhibits lipopolysaccharide/interferon gamma-induced nitric oxide production through modulation of signal transduction in macrophages.
        Biochem. Biophys. Res. Commun. 2011; 411: 143-149
        • Kassiotis G.
        • Kollias G.
        Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination.
        J. Exp. Med. 2001; 193: 427-434
        • Kollias G.
        • Douni E.
        • Kassiotis G.
        • Kontoyiannis D.
        On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.
        Immunol. Rev. 1999; 169: 175-194
        • Kulkarni A.P.
        • Kellaway L.A.
        • Lahiri D.K.
        • Kotwal G.J.
        Neuroprotection from complement-mediated inflammatory damage.
        Ann. N. Y. Acad. Sci. 2004; 1035: 147-164
        • Lassmann H.
        • van Horssen J.
        • Mahad D.
        Progressive multiple sclerosis: pathology and pathogenesis.
        Nat. Rev. Neurol. 2012; 8: 647-656
        • Liu H.
        • Liang X.
        • Wang D.
        • Zhang H.
        • Liu L.
        • Chen H.
        • Li Y.
        • Duan Q.
        • Xie K.
        Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury.
        Shock. 2015;
        • Lock C.
        • Hermans G.
        • Pedotti R.
        • Brendolan A.
        • Schadt E.
        • Garren H.
        • Langer-Gould A.
        • Strober S.
        • Cannella B.
        • Allard J.
        • Klonowski P.
        • Austin A.
        • Lad N.
        • Kaminski N.
        • Galli S.J.
        • Oksenberg J.R.
        • Raine C.S.
        • Heller R.
        • Steinman L.
        Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
        Nat. Med. 2002; 8: 500-508
        • Martin D.
        • Near S.L.
        Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats.
        J. Neuroimmunol. 1995; 61: 241-245
        • Miller D.H.
        • Grossman R.I.
        • Reingold S.C.
        • McFarland H.F.
        The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
        Brain J. Neurol. 1998; 121: 3-24
        • Mirshafiey A.
        • Jadidi-Niaragh F.
        Prostaglandins in pathogenesis and treatment of multiple sclerosis.
        Immunopharmacol. Immunotoxicol. 2010; 32: 543-554
        • Mycko M.P.
        • Papoian R.
        • Boschert U.
        • Raine C.S.
        • Selmaj K.W.
        cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity.
        Brain J. Neurol. 2003; 126: 1048-1057
        • Ohsawa I.
        • Ishikawa M.
        • Takahashi K.
        • Watanabe M.
        • Nishimaki K.
        • Yamagata K.
        • Katsura K.
        • Katayama Y.
        • Asoh S.
        • Ohta S.
        Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.
        Nat. Med. 2007; 13: 688-694
        • Ohta S.
        Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine.
        Pharmacol. Ther. 2014; 144: 1-11
        • Opdenakker G.
        • Van den Steen P.E.
        • Van Damme J.
        Gelatinase B: a tuner and amplifier of immune functions.
        Trends Immunol. 2001; 22: 571-579
        • Ponomarev E.D.
        • Veremeyko T.
        • Barteneva N.
        • Krichevsky A.M.
        • Weiner H.L.
        MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway.
        Nat. Med. 2011; 17: 64-70
        • Robinson A.P.
        • Caldis M.W.
        • Harp C.T.
        • Goings G.E.
        • Miller S.D.
        High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
        J. Autoimmun. 2013; 43: 32-43
        • Ruuls S.R.
        • Bauer J.
        • Sontrop K.
        • Huitinga I.
        • t Hart B.A.
        • Dijkstra C.D.
        Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats.
        J. Neuroimmunol. 1995; 56: 207-217
        • Sato Y.
        • Kajiyama S.
        • Amano A.
        • Kondo Y.
        • Sasaki T.
        • Handa S.
        • Takahashi R.
        • Fukui M.
        • Hasegawa G.
        • Nakamura N.
        • Fujinawa H.
        • Mori T.
        • Ohta M.
        • Obayashi H.
        • Maruyama N.
        • Ishigami A.
        Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice.
        Biochem. Biophys. Res. Commun. 2008; 375: 346-350
        • Sharief M.K.
        • Hentges R.
        Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
        N. Engl. J. Med. 1991; 325: 467-472
        • Sonobe Y.
        • Jin S.
        • Wang J.
        • Kawanokuchi J.
        • Takeuchi H.
        • Mizuno T.
        • Suzumura A.
        Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
        Tohoku J. Exp. Med. 2007; 213: 329-339
        • Stangel M.
        • Penner I.K.
        • Kallmann B.A.
        • Lukas C.
        • Kieseier B.C.
        Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model.
        Ther. Adv. Neurol. Disord. 2015; 8: 3-13
        • Sun Q.
        • Kawamura T.
        • Masutani K.
        • Peng X.
        • Sun Q.
        • Stolz D.B.
        • Pribis J.P.
        • Billiar T.R.
        • Sun X.
        • Bermudez C.A.
        • Toyoda Y.
        • Nakao A.
        Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
        Cardiovasc. Res. 2012; 94: 144-153
        • Takeuchi S.
        • Nagatani K.
        • Otani N.
        • Nawashiro H.
        • Sugawara T.
        • Wada K.
        • Mori K.
        Hydrogen improves neurological function through attenuation of blood–brain barrier disruption in spontaneously hypertensive stroke-prone rats.
        BMC Neurosci. 2015; 16: 22
        • Tian R.
        • Hou Z.
        • Hao S.
        • Wu W.
        • Mao X.
        • Tao X.
        • Lu T.
        • Liu B.
        Hydrogen-rich water attenuates brain damage and inflammation after traumatic brain injury in rats.
        Brain Res. 2016;
        • Tzartos J.S.
        • Friese M.A.
        • Craner M.J.
        • Palace J.
        • Newcombe J.
        • Esiri M.M.
        • Fugger L.
        Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.
        Am. J. Pathol. 2008; 172: 146-155
        • Valmori D.
        • Raffin C.
        • Raimbaud I.
        • Ayyoub M.
        Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors.
        Proc. Natl. Acad. Sci. U. S. A. 2010; 107: 19402-19407
        • Vandenbark A.A.
        • Finn T.
        • Barnes D.
        • Culbertson N.
        • Chou Y.K.
        • Hicks K.
        • Bakke A.
        • Mass M.
        • Whitham R.
        • Offner H.
        • Bourdette D.
        Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene.
        J. Neurosci. Res. 2001; 66: 171-176
        • Xue J.
        • Shang G.
        • Tanaka Y.
        • Saihara Y.
        • Hou L.
        • Velasquez N.
        • Liu W.
        • Lu Y.
        Dose-dependent inhibition of gastric injury by hydrogen in alkaline electrolyzed drinking water.
        BMC Complement. Altern. Med. 2014; 14: 81
        • Yan J.
        • Greer J.M.
        NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis.
        CNS Neurol. Disord. Drug Targets. 2008; 7: 536-557
        • Zhang J.Y.
        • Liu C.
        • Zhou L.
        • Qu K.
        • Wang R.
        • Tai M.H.
        • Lei Lei J.C.
        • Wu Q.F.
        • Wang Z.X.
        A review of hydrogen as a new medical therapy.
        Hepato-Gastroenterology. 2012; 59: 1026-1032
        • Zhang J.
        • Wu Q.
        • Song S.
        • Wan Y.
        • Zhang R.
        • Tai M.
        • Liu C.
        Effect of hydrogen-rich water on acute peritonitis of rat models.
        Int. Immunopharmacol. 2014; 21: 94-101